Protagenic Therapeutics (PTIX) Exec. Chair Armen Garo Buys 5,000 Shares

What Happened

• Armen Garo H, Executive Chair and Principal Officer of Protagenic Therapeutics (PTIX), reported an open-market purchase of 5,000 shares on Aug 5, 2026. The reported purchase price was $0.26 per share for a total reported value of $1,294. This was a buy (purchase) transaction rather than a sale.

Key Details

• Transaction date and price: Aug 5, 2026 — 5,000 shares at $0.26/share (total $1,294). Transaction code: P (purchase).
• Filing date: Form 4 filed Aug 6, 2026 (appears timely under Section 16 reporting rules).
• Shares owned after transaction: Not specified in this filing.
• Footnotes/plan details: No 10b5-1 plan, tax withholding, or other footnotes disclosed on the reported transaction.

Context

• Insider purchases can be more informative than sales because they represent a direct buy of company stock, but the dollar amount here is small — a modest personal purchase rather than a large stake change. The filing appears timely (filed the next day), and no additional disclosures (plans, tax withholding, or cashless exercises) accompany this report.